RANDOMISED CONTROLLED TRIALS COURSE: A Guide to Design, Conduct, Analysis, Interpretation and Reporting
RCT Course 2022 - now in its 20th year.
19-23 September 2022, Merton College, University of Oxford
This annual course provides a thorough grounding in the principles and practice of randomised controlled trials (RCTs) for evaluating healthcare interventions. You will learn from an interdisciplinary faculty of clinicians, statisticians, and trial managers, all with a wealth of RCT experience. The course uses a problem-based learning approach, including lectures and small-group practical sessions, and grounds all learning in practical experience and examples from the literature.
- Clarify the fundamental principles and practice of RCTs
- Present the optimal methodology to use in RCTs
- Examine the critical issues involved in planning, conducting and completing a successful trial
- Provide a basic understanding of the statistics used to plan and analyse RCTs
- Teach critical appraisal skills and practice appraising RCT papers
- Dr Juul Achten, Research Manager, Oxford Trauma and Emergency Care, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
- Prof David Beard, Professor of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
- Associate Prof Jonathan Cook, University Lecturer, Centre for Statistics in Medicine and Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.
- Prof Richard Emsley, Professor of Medical Statistics and Trials Methodology, Institute of Psychiatry, Psychology, and Neuroscience, King's College London.
- Prof Sally Hopewell, Professor of Clinical Trials and and Evidence Synthesis, Centre for Statistics in Medicine and Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.
- Prof Ed Juszczak, Professor of Clinical Trials and Statistics in Medicine, Nottingham Clinical Trials Unit, University of Nottingham
- Prof Graeme MacLennan, Professor of Medical Statistics and Director of the Centre for Health Care Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen.
- Prof Katie Morris, Professor of Obstetrics and Maternal Fetal Medicine and Director of Birmingham Clinical Trials Unit, University of Birmingham
- Dr Ines Rombach, Senior Research Fellow/ Statistician, School of Health and Related Research, The University of Sheffield
- Dr Michael Maia Schlussel, Medical Statistician, Centre for Statistics in Medicine, University of Oxford.
WHO SHOULD ATTEND
If you are planning or actively involved in trials, or are interested in furthering your knowledge of trial methodology, this course is for you. It is ideal for those early in their career or those looking for a refresher course, as it provides an overview of all elements of an RCT. We welcome applications from clinical and non-clinical researchers and other professionals allied to medicine.
Monday 19 September to Friday 23 September 2022
A typical day runs from 9am to 5:30pm, with a banquet on the evening of Thursday 22 September and an early finish at 2pm on Friday 23 September after lunch.
The course will be held at Merton College, a historic college located in Oxford city centre.
£1500 (£1350 if payment is made before 15 May 2022).
Fees include daily lunch and refreshments, a course dinner (Thursday evening), and a comprehensive delegate’s pack including all course materials.
Bed and breakfast accommodation is available at the college for £96 per night.
Course registration will close on 1 August 2022 or when the course is full, whichever is sooner. Please contact Jacqueline Wright for an application form.
Doug Altman Scholarship
Unfortunately, the Doug Altman scholarship will not be running in 2022.
The 2020 scholarship recipient (awarded before course cancellation) will join the 2022 course.
We hope to offer the Doug Altman Scholarship again in 2023.